Statements (37)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Accucaps_Industries
gptkb:Aptar_Group gptkb:Cook_Pharmica gptkb:DPT_Laboratories gptkb:Genevant_Sciences gptkb:Paragon_Bioservices gptkb:Maiden_Pharmaceuticals gptkb:Zynerba_Pharmaceuticals Biosolutions |
| gptkbp:ceo |
gptkb:Alfredo_C._Gangotena
|
| gptkbp:employees |
over 14,000
|
| gptkbp:founded |
gptkb:2007
|
| gptkbp:headquarters |
gptkb:Somerset,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Catalent, Inc.
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:partnership |
gptkb:Eli_Lilly
gptkb:GSK gptkb:temple gptkb:Johnson_&_Johnson gptkb:Sanofi gptkb:Bristol-Myers_Squibb gptkb:Pfizer gptkb:Moderna gptkb:Abb_Vie gptkb:Novartis |
| gptkbp:revenue |
$3.5 billion (2021)
|
| gptkbp:services |
Manufacturing
Drug development Delivery technologies |
| gptkbp:subsidiary |
gptkb:Catalent_Pharma_Solutions
|
| gptkbp:symbol |
CTLT
|
| gptkbp:website |
www.catalent.com
|
| gptkbp:bfsParent |
gptkb:Catalent_Pharma_Solutions
gptkb:Paragon_Bioservices gptkb:Cytiva |
| gptkbp:bfsLayer |
6
|